Related Experiment Video
Updated: Oct 15, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease
Zon-Min Lee1, Chiao-Lun Chu2, Chi-Hsiang Chu3
1Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Taiwan.
Insights
Antibiotic use in children with Kawasaki disease (KD) may increase resistance to immunoglobulin (IVIG) treatment. Multiple antibiotic use correlated with higher IVIG resistance rates, suggesting cautious prescription for suspected infections.
Area of Science:
- Pediatrics
- Rheumatology
- Infectious Diseases
Background:
- Kawasaki disease (KD) is a critical vasculitis affecting young children.
- Antibiotics are frequently given to KD patients before diagnosis due to fever and inflammation.
- The impact of antibiotic exposure on KD treatment outcomes requires investigation.
Purpose of the Study:
- To determine how antibiotic usage affects the treatment outcomes of Kawasaki disease.
- To analyze the relationship between antibiotic administration and immunoglobulin (IVIG) resistance in KD patients.
Main Methods:
- Retrospective chart review of 280 children diagnosed with KD between 2005 and 2017.
- Exclusion of KD patients receiving initial IVIG treatment more than 10 days after symptom onset.
- Comparison of IVIG resistance rates among non-antibiotic users, single-antibiotic users, and multiple-antibiotic users.
Main Results:
- Children receiving multiple antibiotics showed significantly higher IVIG resistance rates (21.6%) compared to non-users (5.6%) and single-drug users (8.9%).
- Increased C-reactive protein (CRP) levels correlated with a higher likelihood of IVIG resistance (p < 0.001).
- White blood cell (WBC) count did not show a significant association with IVIG resistance (p = 0.466).
Conclusions:
- The use of multiple intravenous antibiotics in Kawasaki disease patients is associated with increased IVIG resistance.
- Elevated CRP levels are a predictor of IVIG resistance in KD.
- Physicians should exercise caution when prescribing multiple antibiotics for presumed infections in KD patients to optimize treatment outcomes.
Background:
Kawasaki disease (KD) is a form of systemic vasculitis that primarily affects children under the age of 5 years old. Antibiotics are often prescribed for KD patients even before a diagnosis is made due to their prolonged fever and elevated inflammatory markers. Therefore, the purpose of this study was to investigate the impact of antibiotics usage on the disease outcome of KD.
Methods:
We carried out a retrospective chart review of children between 2005 and 2017 for initial immunoglobulin (IVIG) treatment of KD. KD children with initial IVIG treatment more than 10 days after the onset of symptoms were excluded.
Results:
In total, 280 children were eligible for this study, among which 209 had been treated with antibiotic(s) and 71 had not been. The IVIG resistance rates were 5.6% (4/71), 8.9% (10/112), and 21.6% (21/97) in non-users, single-drug users, and multiple-drug users, respectively (r = 0.205, p = 0.003). The IVIG resistance rate of the multiple antibiotics drug users in KD patients was significantly higher than the other two groups. Furthermore, the likelihood of IVIG resistance was found to increase with elevated C-reactive protein (CRP) values (1.010/unit, p < 0.001) but not with total white blood cell (WBC) count (p = 0.466).
Conclusion:
The probability of IVIG resistance increases with elevated CRP values and the use of multiple IV antibiotics, thus indicating that physicians should be prudent in administering multiple IV antibiotics when treating assumed infections in KD children.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Estimation of k and VD of Aminoglycosides
Dosage Interval and Administration Route: Determination Methods
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

